MissionIR Articles
-
MissionIRNewsBreaks – Brain Scientific Inc.’s (BRSF) E-Tattoo Will Be ‘Next Wave of Innovation for Neurology’
Brain Scientific (OTCQB: BRSF) is a commercial-stage health care company focused on developing innovative and proprietary medical devices and software. As scientists work to understand what causes Parkinson’s, Alzheimer’s, dementia and other neurological issues, BRSF…
-
MissionIRNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Eyes Transformation as Berubicin Becomes Subject of Active Clinical Trials
CNS Pharmaceuticals (NASDAQ: CNSP) is a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system. The company’s pipeline includes Berubicin for the treatment…
-
MissionIRNewsBreaks – Hollywall Entertainment Inc.’s (HWAL) HW Vision to Advance Technological Footprint Through Strategic Agreement
Hollywall Entertainment (OTC: HWAL), an innovative telecommunication and broadcasting company, has begun the rollout of its new wholly owned subsidiary HW Vision. According to a recent update, the subsidiary will provide branded cellular equipment and…
-
XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) Advances Rapid COVID Test System, Expands Psychedelic Medicine Programs
Life sciences industry accelerator XPhyto Therapeutics Corp. has developed a timeline for the approval and rollout of a rapid, portable COVID-19 test it expects to become available by April in Europe XPhyto’s Covid-ID Lab system…
-
PowerTap, an Investee Company of Clean Power Capital Corp. (CSE: MOVE) (FWB: 2K6A) (OTC: MOTNF) Announces USA Hydrogen Station Distribution Model
PowerTap Hydrogen Fueling has signed a definitive agreement with the Andretti Group to create an optimized network by leveraging the latter’s operational expertise and global reach PowerTap plans to have 500 operational hydrogen filling stations…
-
MissionIRNewsBreaks – Amesite (NASDAQ: AMST) Founder, CEO Slated to Present at Upcoming Diamond Equity Research Emerging Growth Conference
Amesite(NASDAQ: AMST) founder and CEO Dr. Ann Marie Sastry is scheduled to present at the Diamond Equity Research Emerging Growth Invitational. The one-day premier event will be held on Wednesday, Feb. 24, with Sastry’s presentation scheduled for…
-
MissionIRNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Featured in Research Report
Processa Pharmaceuticals (NASDAQ: PCSA), a clinical-stage biopharmaceutical company developing products to improve the survival and/or quality of life for patients who have unmet medical needs, was featured in a research report by Encode Ideas L.P.,…
-
VistaGen Therapeutics Inc. (NASDAQ: VTGN) Committed to Developing New Generation Alternatives to Current Standard of Care for Anxiety Disorders
American Psychiatric Association poll reveals 62% of respondents have anxiety about COVID-19 Recent FDA Drug Safety Communication requires updated Boxed Warning for benzodiazepines commonly used to treat anxiety disorders VTGN is committed to developing and…
-
MissionIRNewsBreaks – Clean Power Capital Corp.’s (CSE: MOVE) (OTC: MOTNF) (FWB: 2K6A) PowerTap to Commercialize 3rd Generation Blue Hydrogen System into New Verticals
Clean Power (CSE: MOVE) (OTC: MOTNF) (FWB: 2K6A) today provided additional information about how the onsite hydrogen production and dispensing technology being developed by PowerTap Hydrogen Fueling Corp., an investee company of Clean Power, will…
-
MissionIRNewsBreaks – XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) Announces Expedited Formation of Team to Launch Test System, Also Comments on Lawsuit Against German Subsidiary
XPhyto Therapeutics (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) announced that it has accelerated the creation of a commercial team formed to launch its point-of-care COVID-19 RT-PCR (“RT-PCR”) test system, called the COVID ID Lab. The lab…
-
MissionIRNewsBreaks – Knightscope Inc. CEO Slated to Answer Questions During 90-Minute ‘Ask Me Anything’ Event
Knightscope, an advanced security technology company that builds fully autonomous security robots that deter, detect and report, has announced that its CEO will be answering questions during an upcoming “Ask Me Anything” webinar. The online…
-
MissionIRNewsBreaks – TAAT Lifestyle & Wellness Ltd. (CSE: TAAT) (OTCQB: TOBAF) (FRANKFURT: 2TP2) Announces Record Sales of Flagship Product Since E-Commerce Launch on Feb. 17
TAAT(TM) Lifestyle & Wellness (CSE: TAAT) (OTCQB: TOBAF) (FRANKFURT: 2TP2), a life sciences company dedicated to giving legal-aged smokers the choice to keep the smoking experience that they enjoy with no nicotine and no tobacco, reported…
-
MissionIRNewsBreaks – Augusta Gold Corp. (CSE: G) (OTCQB: BFGCD) (FSE: 11B) Announces Increase of Private Placement
Augusta Gold (CSE: G) (OTCQB: BFGCD) (FSE: 11B) has increased the size of its previously announced private placement; the placement will now comprise 7.56 million units offered at C$2.25 with anticipated gross proceeds of C$17.0 million.…
-
MissionIRNewsBreaks – MustGrow Biologics Corp. (CSE: MGRO) (OTCQB: MGROF) (FRA: 0C0) Set to Benefit from Push Towards Biopesticides
MustGrow (CSE: MGRO) (OTCQB: MGROF) (FRA: 0C0), an agriculture biotech company focused on providing natural science-based biological solutions for high-value crops, looks set to benefit amid new demands and regulatory standards. “The change in market…
-
MissionIRNewsBreaks – Cybin Inc. (NEO: CYBN) (OTC: CLXPF) to Leverage Breakthrough Tech to Measure Real-Time Brain Activity During Psychedelic Experiences
Cybin (NEO: CYBN) (OTC: CLXPF), a life sciences company advancing psychedelic therapeutics for various psychiatric and neurological conditions, recently announced its collaboration with neurotech pioneer HI LLC dba Kernel. According to the update, CYBN will…
-
MissionIRNewsBreaks – Pressure BioSciences Inc. (PBIO) Eyes Lucrative Eco-Friendly Agrochemical Market
Pressure BioSciences (OTCQB: PBIO) (“PBI”), a developer of innovative solutions for the worldwide life science and other industries, has set in motion plans to purchase the assets of an internationally-based, eco-friendly agrochemical developer. An article…
-
MissionIRNewsBreaks – Willow Biosciences Inc. (TSX: WLLW) (OTCQX: CANSF) Secures $28.75M in Bought Deal Offering
Willow Biosciences (TSX: WLLW) (OTCQX: CANSF) has closed its previously announced upsized bought deal offering of 17,424,800 common shares of the company, each at a price of $1.65, including 2,272,800 common shares issued per the…
-
Mohawk Group Holdings Inc. (NASDAQ: MWK) CEO Discusses Entrepreneurship, Embracing Failure, and Acquisitions
Mohawk’s proprietary platform, AIMEE(R), can identify consumer-driven needs and help handle the entire go-to-market process, from determining demand and market opportunities to production under the Mohawk brand The company currently owns 12 brands in the…
-
MissionIRNewsBreaks – 180 Life Sciences Corp. (NASDAQ: ATNF) Announces $11.7M Private Placement
180 Life Sciences (NASDAQ: ATNF), a clinical-stage biotechnology company focused on the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain, today announced its entry into securities purchase agreements with…
-
MissionIRNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) CEO Slated to Host Investor Meetings at Global Healthcare Conference
DarioHealth (NASDAQ: DRIO), a pioneer in the global digital therapeutics market, has announced that CEO Erez Raphael will be participating in the upcoming SVB Leerink Global Healthcare Conference. The 10th annual SVB Leerink Healthcare Conference…
Search Articles
Latest Articles
- A2Z Cust2Mate Solutions Corp. (NASDAQ: AZ) Advancing Retail Innovation Through AI-Powered Smart-Cart Technology
- Forward Industries Inc. (NASDAQ: FWDI) Positive Update for Shareholders After Debuting the Company’s Solana Treasury Strategy
- Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) Secures Funding to Strengthen North American Supply Chain
- MissionIRNewsBreaks – Soligenix Inc. (NASDAQ: SNGX) Featured in BioMedWire Editorial on Rare Disease Therapies
- MissionIRNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) CEO Talks Bold Strategy to Treat GBM in BioMedWire Podcast